Short answer: there is no researched human S23 dosage. S-23 has only been studied in rats, as a potential male contraceptive, and in anti-doping excretion studies; it has never been tested for muscle or safety in people (Jones 2009). Users commonly report 5–10 mg a day, and some 10–30 mg, for about 8 weeks, nearly always followed by Clomid. The old claim that S23 has been used in “human trials” for dosing was wrong.

S23 Summary

S-23 bound the androgen receptor very tightly and acted as a full agonist in lab tests. In rats (Jones 2009):

  • 14 days at more than 0.1 mg/day cut LH by more than half, with a smaller prostate but a larger levator ani muscle.
  • With estradiol for up to 10 weeks, 4 of 6 rats had no sperm and none of 6 caused a pregnancy; the effect on sperm production was biphasic with dose, and fertility fully returned 100 days after stopping.
  • Lean mass and bone density rose and fat mass fell with dose.

None of this has been studied in people. The only human data come from anti-doping work: one volunteer’s single ~8 mg dose was found in urine for 28 days (Ameline 2022). Full profile: S23 review.

S23 Half-Life

The human half-life of S-23 is not established, and we could not confirm the 12-hour rat figure quoted in the old version of this page. Users split the daily amount into two doses on the assumption of a short half-life; that has not been tested. For detection: a single 50 µg micro-dose was traceable for about 544 hours on average (Alhalabi 2025).

S23 Bulking Dosage + Example Cycle

Evidence level: anecdotal. No S23 dose has been tested in people; these are doses users report, kept from the original article. Not a protocol.

Commonly reported S23 After
Weeks 1–8 10 mg/day /
Weeks 9–12 / Clomid (users report 50 mg, then 25 mg/day)

Users usually run S23 alone because it is strongly suppressive in rats. Whether a month of Clomid restores testosterone after S23 has not been studied; see Clomid PCT for what is known about clomiphene. Reader reports with this pattern are on S23 before and after.

S23 Cutting Dosage + Example Cycle

Evidence level: anecdotal. No S23 dose has been tested in people; these are doses users report, kept from the original article. Not a protocol.

Commonly reported S23 After
Weeks 1–8 5 mg/day /
Weeks 9–12 / Clomid (users report 25 mg/day)

In rats, fat mass fell with dose (Jones 2009); fat loss in people has not been measured.

No PCT S23 SARM Dosage?

There is no known no-PCT dose. In rats, LH fell by more than half at doses above 0.1 mg/day within two weeks (Jones 2009), and every reader report on our S23 pages describes running a SERM afterwards. Lowering the dose has not been shown to avoid suppression. Bloodwork before and after (testosterone, LH, FSH; semen analysis if fertility matters) is the only way to see the effect. See the PCT and bloodwork planner.

Safest S23 SARM Dosage

No S23 dose has been shown to be safe in people. The original author suggested 5 mg a day to limit side effects such as aggression, night sweats and suppression (anecdotal). What the rat data add: the main effect S23 was designed for is suppression of the hormones that drive sperm production, which is relevant to anyone who wants children.

What S23 SARM Dosage Should I Take

We can’t recommend a dose for an untested drug. Users describe starting at 5 mg a day and not going above 10 mg; the original author reported his best gains at 10 mg (anecdotal). Practical points: at 10 mg/ml, 0.5 ml contains 5 mg; products are often mislabeled, with only 41% of 44 tested SARM products matching their label (Van Wagoner 2017). For a SARM with human dosing data, see LGD-4033 dosage or ostarine dosage.

Conclusion

Every S23 dose you will read is anecdotal: S-23 has only rat data, where it strongly suppressed LH and, with estrogen, stopped sperm production until well after treatment ended. Users report 5–10 mg a day with a Clomid PCT, but none of that has been studied. If you weigh it up, start from the fertility and suppression data, get bloodwork, and compare with compounds that have human trials in the SARMs database.

Frequently asked questions

What is the S23 dosage?

No researched human doseEvidence: User reports

S-23 has only been studied in rats. Users commonly report 5–10 mg a day, sometimes more; these are anecdotal numbers, not tested doses.

Read the full section

Do you need PCT after S23?

No dose avoids suppressionEvidence: Animal

No dose has been shown to avoid suppression. In rats, S-23 cut LH by more than half within two weeks.

Read the full section

What is the half-life of S23?

Not established in humansEvidence: Limited

No human half-life has been published. The 12-hour figure often quoted has no source that could be confirmed.

Read the full section

Does S23 affect fertility?

Yes in rats; untested in peopleEvidence: Animal

It was developed as a male contraceptive: in rats given S-23 with estradiol, 4 of 6 had no sperm and none caused a pregnancy, and fertility returned 100 days after stopping. This has not been tested in people.

Read the full section

Is S23 the strongest SARM?

Unknown in peopleEvidence: Lab

It binds the androgen receptor very tightly in lab tests, but strength in a test tube is not the same as effectiveness or safety in people, which have never been studied.

Read the full section

Sources

  1. Preclinical characterization of a (S)-N-(4-cyano-3-trifluoromethyl-phenyl)-3-(3-fluoro, 4-chlorophenoxy)-2-hydroxy-2-methyl-propanamide: a selective androgen receptor modulator for hormonal male contraception 2009 · PMID 18772237
  2. In vitro characterization of S-23 metabolites produced by human liver microsomes, and subsequent application to urine after a controlled oral administration 2022 · PMID 35182830
  3. Investigations Into the Urinary Metabolite Elimination Profile of the Selective Androgen Receptor Modulator S-23 in Studies Mimicking Contaminated Product Ingestion for Doping Control Purposes 2025 · PMID 40277337
  4. Chemical Composition and Labeling of Substances Marketed as Selective Androgen Receptor Modulators and Sold via the Internet 2017 · PMID 29183075
  5. PubChem: S-23 (CID 24892822), names and synonyms 2026